The Role of Molecular Genetic Alterations in Sensitivity of the Adjuvant Intravesical Therapy for Non-Muscle Invasive Bladder Cancer

Onkourologiya - Russian Federation
doi 10.17650/1726-9776-2018-14-4-124-138
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House ABV Press

Related search

Intravesical Coxsackievirus A21 Therapy for Non-Muscle Invasive Bladder Cancer

Bladder Cancer
OncologyUrology
2020English

Advances in Intravesical Therapy for the Treatment of Non-Muscle Invasive Bladder Cancer (Review)

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Humoral Immune Factor Changes in Group of Patients With Non-Muscle Invasive Bladder Cancer Treated With Intravesical Therapy.

Journal of the faculty of medicine baghdad
2017English

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2011English

Long-Term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-Invasive Bladder Cancer Refractory to Standard Intravesical Therapy

Urology
Urology
2010English

The Use of Water-Soluble Mucoadhesive Gels for the Intravesical Delivery of Epirubicin to the Bladder for the Treatment of Non-Muscle-Invasive Bladder Cancer

Journal of Pharmacy and Pharmacology
PharmacologyPharmaceutical Science
2015English

The Effectiveness of Single Shot Intravesical Chemotherapy With Mitomycin-C in Preventing Recurrence of Non-Muscle Invasive Bladder Cancer

Journal of Gandhara Medical and Dental Science
2016English

Multi-Institutional Analysis of Sequential Intravesical Gemcitabine and Mitomycin C Chemotherapy for Non–muscle Invasive Bladder Cancer

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2014English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy